arrow
S

Sanjay Singh

siddhartha institute of pharmacy
H指数:31
被引数:3,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study

GBL1204的安全性评估——一种用于新生血管性年龄相关性黄斑变性的预充式贝伐珠单抗眼用制剂:一项I期研究

2026-06-030
OAAI
LmCen-/- based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia
2025-02-140
OAAI
Prospective Observational Cohort Study of Tenecteplase: Results From the Indian Registry in Ischemic Stroke-Tenecteplase
2024-11-220
OAAI
Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field

从多诺瓦尼利什曼原虫生产利什曼蛋白皮肤测试抗原,以便将来在野外重新引入

2023-11-023
OAAI
Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis

针对载体传播的致命内脏利什曼病的减毒皮肤利什曼原虫活疫苗的临床前验证

2021-07-3031
OAAI
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
2018-09-2858
OAAI
Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection

吸附在阳离子脂质体佐剂CAF09上的恶性疟原虫CSP诱导的强大抗体和CD8 T细胞反应赋予对实验性啮齿动物疟疾感染的杀菌免疫

2017-04-1038
OAAI